封面
市场调查报告书
商品编码
1585196

全球关节疼痛注射市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Joint Pain Injections Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: | 出版商: Value Market Research | 英文 170 Pages | 商品交期: 最快1-2个工作天内

价格

全球关节疼痛注射市场需求预计将从 2023 年的 61.2 亿美元达到近 127 亿美元的市场规模,2024-2032 年研究期间复合年增长率为 8.44%。

关节疼痛注射是一种微创治疗方法,用于缓解关节疼痛和炎症,这些疼痛和发炎通常由关节炎、损伤或退化性疾病引起。这些注射剂可能含有皮质类固醇、透明质酸或再生医学成分,如富含血小板的血浆 (PRP)。皮质类固醇注射可减轻炎症,而透明质酸可改善关节润滑和缓衝作用。 PRP 和其他再生疗法可促进自然癒合和组织修復。这些注射直接注射到受影响的关节中,可以提供有针对性的缓解,并可以延迟手术的需要。它们广泛用于骨科,以增强慢性关节疼痛患者的活动能力并改善生活品质。

市场动态

肌肉骨骼疾病的日益普及以及更容易出现关节相关问题的人口老化推动了关节疼痛注射市场的发展。骨关节炎和类风湿关节炎病例不断增加,增加了对关节疼痛注射等有效疼痛管理解决方案的需求。对微创治疗的日益偏好是另一个关键因素,因为关节疼痛注射无需手术即可缓解。注射疗法的进步,例如富血小板血浆 (PRP) 和透明质酸注射液的开发,正在增强关节疼痛注射的功效和安全性。运动伤害也促进了市场的成长,运动员和活跃的个人寻求快速有效的疼痛缓解。人们对关节健康的认识不断提高,先进的医疗设施也越来越多,这正在支持关节止痛注射剂的采用。此外,旨在创造更持久、更有针对性的注射剂的研发工作正在推动该领域的创新。关节止痛注射的保险范围和报销政策也对市场产生正面影响。非侵入性治疗的日益普及以及与重复注射相关的安全问题可能会挑战未来几年的市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外,这些工具还对全球关节疼痛注射市场的每个细分市场进行了包容性评估。关节疼痛注射产业的成长和趋势为本研究提供了整体方法。

市场区隔

关节疼痛注射市场报告的这一部分提供了国家和区域层面的细分市场的详细资料,从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按接头类型

  • 膝盖和脚踝
  • 髋关节
  • 肩部和肘部
  • 脊椎小关节
  • 其他的

按註射类型

  • 皮质类固醇注射剂
  • 玻尿酸注射液
  • 其他的

按配销通路

  • 医院药房
  • 零售药局
  • 网路药局

区域分析

本节涵盖区域前景,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲关节疼痛注射市场当前和未来的需求。此外,该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。关节疼痛注射市场的主要参与者包括艾尔建公司(Allergan Plc)、辉瑞公司(Pfizer Inc.)、赛诺菲(Sanofi)、Anika Therapeutics Inc.、Ferring BV、Bioventus、Flexion Therapeutics Inc.、Zimmer Biomet Holdings Inc.、Seikagaku Corporation、Chugai Pharmaceutical Co. Ltd.。新产品发布和其他发展。

如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章:前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章:执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章:关节疼痛注射 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按联合类型分類的市场吸引力分析
    • 按註射类型分類的市场吸引力分析
    • 按配销通路分類的市场吸引力分析
    • 市场吸引力分析:按地区

第 4 章:价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章:全球关节疼痛注射剂市场分析:按关节类型

  • 按接头类型概述
  • 按接头类型进行历史和预测资料分析
  • 膝盖和脚踝
  • 髋关节
  • 肩部和肘部
  • 脊椎小关节
  • 其他的

第 6 章:全球关节疼痛注射剂市场分析:按註射剂类型

  • 按註射类型概述
  • 按註射类型进行历史和预测资料分析
  • 皮质类固醇注射剂
  • 玻尿酸注射液
  • 其他的

第 7 章:全球关节疼痛注射剂市场分析:按分销管道

  • 配销通路概述
  • 按配销通路进行历史和预测资料分析
  • 医院药房
  • 零售药局
  • 网路药局

第 8 章:全球关节疼痛注射剂市场分析:依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 9 章:关节止痛注射公司的竞争格局

  • 关节止痛注射剂市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 10 章:公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Allergan Plc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Pfizer Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Sanofi
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Anika Therapeutics Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Ferring BV
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Bioventus
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Flexion Therapeutics Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Zimmer Biomet Holdings Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Seikagaku Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Chugai Pharmaceutical Co. Ltd
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中,财务详细资讯和最新发展视情况而定,或对私人公司而言可能不包括在内

Product Code: VMR11210961

The global demand for Joint Pain Injections Market is presumed to reach the market size of nearly USD 12.7 Billion by 2032 from USD 6.12 Billion in 2023 with a CAGR of 8.44% under the study period 2024-2032.

Joint Pain Injections are minimally invasive treatments used to relieve pain and inflammation in joints, commonly caused by arthritis, injuries, or degenerative conditions. These injections may contain corticosteroids, hyaluronic acid, or regenerative medicine components like platelet-rich plasma (PRP). Corticosteroid injections reduce inflammation, while hyaluronic acid improves joint lubrication and cushioning. PRP and other regenerative therapies promote natural healing and tissue repair. Administered directly into the affected joint, these injections provide targeted relief and can delay the need for surgery. They are widely used in orthopedics to enhance mobility and improve the quality of life for patients with chronic joint pain.

Market Dynamics

The Joint Pain Injections market is being driven by the increasing prevalence of musculoskeletal disorders and an aging population that is more susceptible to joint-related issues. Osteoarthritis and rheumatoid arthritis cases are on the rise, boosting the demand for effective pain management solutions like Joint Pain Injections. The growing preference for minimally invasive treatments is another key factor, as Joint Pain Injections offer relief without the need for surgery. Advances in injection therapies, such as the development of platelet-rich plasma (PRP) and hyaluronic acid injections, are enhancing the efficacy and safety of Joint Pain Injections. Sports injuries are also contributing to market growth, with athletes and active individuals seeking quick and effective pain relief. The increasing awareness of joint health and the availability of advanced healthcare facilities are supporting the adoption of Joint Pain Injections. Moreover, research and development efforts to create longer-lasting and more targeted injections are driving innovation in the field. Insurance coverage and reimbursement policies for Joint Pain Injections are also positively impacting the market. The increasing availability of non-invasive treatments and safety concerns associated with repeated injections may challenge market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Joint Pain Injections. The growth and trends of Joint Pain Injections industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Joint Pain Injections market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Joint Type

  • Knee & Ankle
  • Hip Joint
  • Shoulder & Elbow
  • Facet Joints of Spine
  • Others

By Injection Type

  • Corticosteroid Injections
  • Hyaluronic Acid Injections
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Joint Pain Injections market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Joint Pain Injections market include Allergan Plc, Pfizer Inc., Sanofi, Anika Therapeutics Inc., Ferring B.V., Bioventus, Flexion Therapeutics Inc., Zimmer Biomet Holdings Inc., Seikagaku Corporation, Chugai Pharmaceutical Co. Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. JOINT PAIN INJECTIONS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Joint Type
    • 3.7.2 Market Attractiveness Analysis By Injection Type
    • 3.7.3 Market Attractiveness Analysis By Distribution Channel
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL JOINT PAIN INJECTIONS MARKET ANALYSIS BY JOINT TYPE

  • 5.1. Overview By Joint Type
  • 5.2. Historical and Forecast Data Analysis By Joint Type
  • 5.3. Knee & Ankle Historic and Forecast Sales By Regions
  • 5.4. Hip Joint Historic and Forecast Sales By Regions
  • 5.5. Shoulder & Elbow Historic and Forecast Sales By Regions
  • 5.6. Facet Joints of Spine Historic and Forecast Sales By Regions
  • 5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL JOINT PAIN INJECTIONS MARKET ANALYSIS BY INJECTION TYPE

  • 6.1. Overview By Injection Type
  • 6.2. Historical and Forecast Data Analysis By Injection Type
  • 6.3. Corticosteroid Injections Historic and Forecast Sales By Regions
  • 6.4. Hyaluronic Acid Injections Historic and Forecast Sales By Regions
  • 6.5. Others Historic and Forecast Sales By Regions

7. GLOBAL JOINT PAIN INJECTIONS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 7.1. Overview By Distribution Channel
  • 7.2. Historical and Forecast Data Analysis By Distribution Channel
  • 7.3. Hospital Pharmacies Historic and Forecast Sales By Regions
  • 7.4. Retail Pharmacies Historic and Forecast Sales By Regions
  • 7.5. Online Pharmacies Historic and Forecast Sales By Regions

8. GLOBAL JOINT PAIN INJECTIONS MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE JOINT PAIN INJECTIONS COMPANIES

  • 9.1. Joint Pain Injections Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF JOINT PAIN INJECTIONS INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Allergan Plc
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Pfizer Inc.
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Sanofi
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Anika Therapeutics Inc.
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Ferring B.V.
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Bioventus
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Flexion Therapeutics Inc.
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Zimmer Biomet Holdings Inc.
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Seikagaku Corporation
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Chugai Pharmaceutical Co. Ltd
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Joint Type (USD MN)
  • Knee & Ankle Market Sales By Geography (USD MN)
  • Hip Joint Market Sales By Geography (USD MN)
  • Shoulder & Elbow Market Sales By Geography (USD MN)
  • Facet Joints of Spine Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Injection Type (USD MN)
  • Corticosteroid Injections Market Sales By Geography (USD MN)
  • Hyaluronic Acid Injections Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Global Joint Pain Injections Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Joint Pain Injections Report
  • Market Research Process
  • Market Research Methodology
  • Global Joint Pain Injections Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Joint Type
  • Market Attractiveness Analysis By Injection Type
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Joint Type (USD MN)
  • Knee & Ankle Market Sales By Geography (USD MN)
  • Hip Joint Market Sales By Geography (USD MN)
  • Shoulder & Elbow Market Sales By Geography (USD MN)
  • Facet Joints of Spine Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Injection Type (USD MN)
  • Corticosteroid Injections Market Sales By Geography (USD MN)
  • Hyaluronic Acid Injections Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.